We found that GREB1 is transcriptionally activated by SRC-2 via the progesterone–PR axis in endometrium [40], and a novel fusion gene, GREB1-SRC-2, was detected in uterine sarcoma [41]. The gene discussed is GREB1; the disease is uterine corpus sarcoma.